These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 4784173

  • 21. Mood changes during l-dopa therapy.
    Anumonye A.
    J Med Soc N J; 1972 Feb; 69(2):139-43. PubMed ID: 4550284
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases].
    Pimenta Ada M, Friguglietti DJ.
    Rev Bras Med; 1971 Sep; 28(9):481-96. PubMed ID: 5139650
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
    Sato G, Ito H, Handa Y, Takahashi I, Iijima K.
    No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821
    [No Abstract] [Full Text] [Related]

  • 27. [Parkinson's disese. Treatment with L-dopa].
    Herskovits E, Matera R.
    Prensa Med Argent; 1969 Oct 31; 56(35):1674-80. PubMed ID: 5399419
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J, Dupont E, Mikkelsen B.
    Ugeskr Laeger; 1971 Nov 26; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
    Boudouresques J, Khalil R, Vigouroux RA, Gosset A, Daniel F, Dufour H.
    Mars Med; 1971 Nov 26; 108(2):85-9. PubMed ID: 5548385
    [No Abstract] [Full Text] [Related]

  • 33. Quantitative effects of L-dopa on different types of movements and muscle tone in Parkinsonian patients.
    Knutsson E, Mårtensson A.
    Scand J Rehabil Med; 1971 Nov 26; 3(3):121-30. PubMed ID: 5156174
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa].
    Paci A, Freddi A, Barba C.
    Riv Neurol; 1973 Nov 26; 43(1):15-39. PubMed ID: 4698011
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [L-Dopa in the treatment of Parkinson's disease].
    Warot P.
    Lille Med; 1971 Nov 26; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract] [Full Text] [Related]

  • 39. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I.
    J Med Assoc State Ala; 1971 May 26; 40(11):709-18. PubMed ID: 5573008
    [No Abstract] [Full Text] [Related]

  • 40. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J, Raymondeaud C, Piot C.
    Rev Neurol (Paris); 1970 Feb 26; 122(2):145-8. PubMed ID: 4931718
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.